Mylan Remains Firmly Negative In Late-Day Trading

( - After falling sharply earlier in the session, shares of Mylan ( MYL ) continue to see considerable weakness in late-day trading on Thursday. Mylan is currently down by 2.2 percent.

Mylan came under pressure after U.S. health regulators were unable to approve the drug maker's generic version of asthma medication Advair due to "minor deficiencies."

Read the original article on RTTNews (

For comments and feedback: contact

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.